Your browser doesn't support javascript.
loading
Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance.
Tsagkas, Charidimos; Parmar, Katrin; Pezold, Simon; Barro, Christian; Chakravarty, Mallar M; Gaetano, Laura; Naegelin, Yvonne; Amann, Michael; Papadopoulou, Athina; Wuerfel, Jens; Kappos, Ludwig; Kuhle, Jens; Sprenger, Till; Granziera, Cristina; Magon, Stefano.
Afiliação
  • Tsagkas C; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Parmar K; Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Pezold S; Medical Image Analysis Center AG, Basel, Switzerland.
  • Barro C; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Chakravarty MM; Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Gaetano L; Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland.
  • Naegelin Y; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Amann M; Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Papadopoulou A; Department of Psychiatry, McGill University, Montreal, QC, Canada.
  • Wuerfel J; Cerebral Imaging Centre-Douglas Mental Health University Institute, Verdun, QC, Canada.
  • Kappos L; Department of Biomedical Engineering, McGill University, Montreal, QC, Canada.
  • Kuhle J; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Sprenger T; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Granziera C; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Magon S; Medical Image Analysis Center AG, Basel, Switzerland.
Hum Brain Mapp ; 42(8): 2399-2415, 2021 06 01.
Article em En | MEDLINE | ID: mdl-33624390
There is evidence that multiple sclerosis (MS) pathology leads to distinct patterns of volume loss over time (VLOT) in different central nervous system (CNS) structures. We aimed to use such patterns to identify patient subgroups. MS patients of all classical disease phenotypes underwent annual clinical, blood, and MRI examinations over 6 years. Spinal, striatal, pallidal, thalamic, cortical, white matter, and T2-weighted lesion volumes as well as serum neurofilament light chain (sNfL) were quantified. CNS VLOT patterns were identified using principal component analysis and patients were classified using hierarchical cluster analysis. 225 MS patients were classified into four distinct Groups A, B, C, and D including 14, 59, 141, and 11 patients, respectively). These groups did not differ in baseline demographics, disease duration, disease phenotype distribution, and lesion-load expansion. Interestingly, Group A showed pronounced spinothalamic VLOT, Group B marked pallidal VLOT, Group C small between-structure VLOT differences, and Group D myelocortical volume increase and pronounced white matter VLOT. Neurologic deficits were more severe and progressed faster in Group A that also had higher mean sNfL levels than all other groups. Group B experienced more frequent relapses than Group C. In conclusion, there are distinct patterns of VLOT across the CNS in MS patients, which do not overlap with clinical MS subtypes and are independent of disease duration and lesion-load but are partially associated to sNfL levels, relapse rates, and clinical worsening. Our findings support the need for a more biologic classification of MS subtypes including volumetric and body-fluid markers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medula Espinal / Encéfalo / Progressão da Doença / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medula Espinal / Encéfalo / Progressão da Doença / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article